Page last updated: 2024-09-03

cercosporamide and Cancer of Kidney

cercosporamide has been researched along with Cancer of Kidney in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, S; Cui, L; Hu, Q; Jiang, Y; Shen, Y; Zhao, J	1

Other Studies

1 other study(ies) available for cercosporamide and Cancer of Kidney

Article	Year
Preclinical evidence that MNK/eIF4E inhibition by cercosporamide enhances the response to antiangiogenic TKI and mTOR inhibitor in renal cell carcinoma. Biochemical and biophysical research communications, 2020, 09-10, Volume: 530, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Benzofurans; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Synergism; Eukaryotic Initiation Factor-4E; Humans; Intracellular Signaling Peptides and Proteins; Kidney Neoplasms; Mice, SCID; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Sirolimus; Sunitinib; TOR Serine-Threonine Kinases	2020

Article

Year

Preclinical evidence that MNK/eIF4E inhibition by cercosporamide enhances the response to antiangiogenic TKI and mTOR inhibitor in renal cell carcinoma.

Biochemical and biophysical research communications, 2020, 09-10, Volume: 530, Issue:1

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Benzofurans; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Synergism; Eukaryotic Initiation Factor-4E; Humans; Intracellular Signaling Peptides and Proteins; Kidney Neoplasms; Mice, SCID; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Sirolimus; Sunitinib; TOR Serine-Threonine Kinases

2020